Clinical Trial: A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07059000) titled 'A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)' on June 18.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Chronic Primary Immune Thrombocytopenia (ITP)

Intervention: BIOLOGICAL: Kedrion IVIG 10%

(Intravenous) Human Normal Immunoglobulin (IVIg) 10%

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Kedrion S.p.A.

Disclaimer: Curated by HT Syndication....